What does APITOPE INTERNATIONAL do?

APITOPE INTERNATIONAL is a healthcare practice in Diepenbeek. Public Limited, started on 21 October 2008, 1 establishment.

What is the address of APITOPE INTERNATIONAL?

The registered office of APITOPE INTERNATIONAL is located at Agoralaan A-BIS, 3590 Diepenbeek.

Is APITOPE INTERNATIONAL still active?

Yes. According to the CBE (29 October 2026) APITOPE INTERNATIONAL is active, legal situation “Normale toestand”, started on 21 October 2008.

Is APITOPE INTERNATIONAL registered on Peppol?

Yes, APITOPE INTERNATIONAL is registered on the Peppol network with ID 0208:0807253103.

What is the enterprise number of APITOPE INTERNATIONAL?

The enterprise number of APITOPE INTERNATIONAL is BE0807253103.

When was APITOPE INTERNATIONAL founded?

APITOPE INTERNATIONAL was founded on 21 October 2008.

Who are the directors of APITOPE INTERNATIONAL?

According to the 2025 annual accounts, the directors of APITOPE INTERNATIONAL are: LRM Bheer NV, SGV Management Services BV, Hayley French.

Is APITOPE INTERNATIONAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 October 2008; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did APITOPE INTERNATIONAL make in 2025?

APITOPE INTERNATIONAL posted a profit after taxes of € 471,830 in financial year 2025.

What is the revenue of APITOPE INTERNATIONAL?

As a small company, APITOPE INTERNATIONAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 475,244.

APITOPE INTERNATIONAL (Public Limited) - Diepenbeek

Dossier APITOPE INTERNATIONAL, printed on 29 October 2026 from databakkes.be/en/0807253103/apitope-international. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APITOPE INTERNATIONAL from Diepenbeek, company number BE0807253103, closed financial year 2025 with a result of € 471,830 after tax. For that financial year APITOPE INTERNATIONAL recorded a gross margin of € 475,244 and equity of € 264,150. Compared with financial year 2024, the result moved from € -74,299 to € 471,830. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 23, 2026.

What it is worth Growing

€ 264,150

▲ € 221,830 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 471,830

▲ still € 74,299 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,038

▼ 95% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 250,000 paid out

53 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 38,913

▼ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 248,093 Gross margin 2022: € 248,093 First fiscal year in the series	€ -58,310 Gross margin 2023: € -58,310 ▼ € 306,404 vs 2022 (€ 248,093) Unfavourable step	€ -16,518 Gross margin 2024: € -16,518 ▲ € 41,792 vs 2023 (€ -58,310) Favourable step	€ 475,244 Gross margin 2025: € 475,244 ▲ € 491,762 vs 2024 (€ -16,518) Favourable step	▲ € 491,762
Profit after taxes	€ 213,794 Profit after taxes 2022: € 213,794 First fiscal year in the series	€ -56,785 Profit after taxes 2023: € -56,785 ▼ € 270,579 vs 2022 (€ 213,794) Unfavourable step	€ -74,299 Profit after taxes 2024: € -74,299 ▼ € 17,514 vs 2023 (€ -56,785) Unfavourable step	€ 471,830 Profit after taxes 2025: € 471,830 ▲ € 546,128 vs 2024 (€ -74,299) Favourable step	▲ € 546,128
Equity	€ 173,404 Equity 2022: € 173,404 First fiscal year in the series	€ 116,619 Equity 2023: € 116,619 ▼ 33% vs 2022 (€ 173,404) Unfavourable step	€ 42,320 Equity 2024: € 42,320 ▼ 64% vs 2023 (€ 116,619) Unfavourable step	€ 264,150 Equity 2025: € 264,150 ▲ € 221,830 vs 2024 (€ 42,320) Favourable step	▲ € 221,830
Total debts	€ 2,944,409 Total debts 2022: € 2,944,409 First fiscal year in the series	€ 2,726,836 Total debts 2023: € 2,726,836 ▼ 7% vs 2022 (€ 2,944,409) Favourable step	€ 48,504 Total debts 2024: € 48,504 ▼ 98% vs 2023 (€ 2,726,836) Favourable step	€ 288,913 Total debts 2025: € 288,913 ▲ € 240,409 vs 2024 (€ 48,504) Unfavourable step	▲ € 240,409
Cash	€ 297,623 Cash 2022: € 297,623 First fiscal year in the series	€ 39,062 Cash 2023: € 39,062 ▼ 87% vs 2022 (€ 297,623) Unfavourable step	€ 66,992 Cash 2024: € 66,992 ▲ 72% vs 2023 (€ 39,062) Favourable step	€ 3,038 Cash 2025: € 3,038 ▼ 95% vs 2024 (€ 66,992) Unfavourable step	▼ 95%
Retained profit	€ 13,794 Retained profit 2022: € 13,794 First fiscal year in the series	€ -42,990 Retained profit 2023: € -42,990 ▼ € 56,785 vs 2022 (€ 13,794) Unfavourable step	€ -117,289 Retained profit 2024: € -117,289 ▼ € 74,299 vs 2023 (€ -42,990) Unfavourable step	€ 104,541 Retained profit 2025: € 104,541 ▲ € 221,830 vs 2024 (€ -117,289) Favourable step	▲ € 221,830
Dividend	€ 200,000 Dividend 2022: € 200,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 200,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 250,000 Dividend 2025: € 250,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 3,117,813 Balance sheet total 2022: € 3,117,813 First fiscal year in the series	€ 2,843,455 Balance sheet total 2023: € 2,843,455 ▼ 9% vs 2022 (€ 3,117,813) Unchanged	€ 90,825 Balance sheet total 2024: € 90,825 ▼ 97% vs 2023 (€ 2,843,455) Unchanged	€ 553,063 Balance sheet total 2025: € 553,063 ▲ € 462,239 vs 2024 (€ 90,825) Unchanged	▲ € 462,239

Key figures of APITOPE INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APITOPE INTERNATIONAL?

What happened at APITOPE INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Hayley French stepped down as director. NBB
2027 LRM Bheer NV stepped down as director. NBB
2027 SGV Management Services BV stepped down as director. NBB
Mar 23, 2026 New annual accounts for financial year 2025: profit of € 471,830. Source: NBB ↗
2021 LRM Bheer NV became a director. NBB
2021 SGV Management Services BV became a director. NBB
2019 Hayley French became a director. NBB
Oct 21, 2008 New establishment in Diepenbeek. KBO

In short

From € 213,794 profit in 2022 to € 471,830 profit in 2025.

Paid € 254 in corporate taxes since 2022.

Best year ever: 2025, with € 471,830 profit.

Paid out € 450,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

LIMBURGSE RECONVERSIE MAATSCHAPPIJ 28.5%

The stake of LIMBURGSE RECONVERSIE MAATSCHAPPIJ comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APITOPE INTERNATIONAL

The shares are held by LIMBURGSE RECONVERSIE MAATSCHAPPIJ (28.5%).

Directors

According to the 2025 annual accounts

LRM Bheer NV

Director · represented by Tom Aerts

Also active at: Transport Marcel Depaire, Trafuco, Beltra - B, MIJNSCHADE EN BEMALING LIMBURGS MIJNGEBIED, BlooLoc, be-DIVE, LRM Lease, RMW +62 more

since 2021 · until 2027

SGV Management Services BV

Chairman of the board · represented by Stéphane Verdood

since 2021 · until 2027

Hayley French

Managing director

since 2019 · until 2030

Shareholders

LIMBURGSE RECONVERSIE MAATSCHAPPIJ

28.5%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Agoralaan A-BIS

3590 Diepenbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0807.253.103

VAT number

BE 0807.253.103

Registered office

Agoralaan A-BIS, 3590 Diepenbeek

Names & denominations

APITOPE INTERNATIONAL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

21 October 2008

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

APITOPE INTERNATIONAL

Financials

What happened to APITOPE INTERNATIONAL?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions